Stoke Therapeutics, Inc.

Historical 13F Holders

Symbol
STOK
CUSIP
86150R107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 131 63.4 M $422 M
2024 Q4 134 58.1 M $640 M
2024 Q3 125 58.4 M $718 M
2024 Q2 122 65.8 M $890 M
2024 Q1 116 62.3 M $841 M
2023 Q4 88 49.8 M $262 M
2023 Q3 103 43.9 M $173 M
2023 Q2 107 46.5 M $495 M
2023 Q1 100 44.6 M $372 M
2022 Q4 111 40.7 M $376 M
2022 Q3 108 42.3 M $544 M
2022 Q2 96 43.1 M $569 M
2022 Q1 103 41.4 M $871 M
2021 Q4 98 35.5 M $856 M
2021 Q3 92 19.4 M $492 M
2021 Q2 102 20.9 M $703 M
2021 Q1 114 39.1 M $1.52 B
2020 Q4 103 38.7 M $2.40 B
2020 Q3 93 34.6 M $1.16 B
2020 Q2 72 34.9 M $825 M
2020 Q1 69 34.8 M $796 M
2019 Q4 66 33.6 M $952 M
2019 Q3 56 16.1 M $341 M
2019 Q2 49 14.3 M $410 M